Pharming Group NV(PHAR.US)

Last Updated 19:00:00 ET
longbridge loading

Pharming Group Balances Near-Term Strain With Joenja Growth

Tip Ranks·
US
PHAR
-0.36%
US
ARKG
+3.32%
US
SBIO
+1.80%
Tip Ranks·
US
PHAR
-0.36%
US
ARKG
+3.32%
US
SBIO
+1.80%

Pharming Group (OTCMKTS:PHGUF) Releases Quarterly Earnings Results

Market Beat·
US
PHAR
-0.36%
US
SBIO
+1.80%
US
IBBQ
+0.89%
Market Beat·
US
PHAR
-0.36%
US
SBIO
+1.80%
US
IBBQ
+0.89%

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026

Tip Ranks·
US
IVA
+1.36%
US
PHAR
-0.36%
US
ATAI
+5.70%
Tip Ranks·
US
IVA
+1.36%
US
PHAR
-0.36%
US
ATAI
+5.70%

Pharming Group (PHAR) Gets a Buy from Canaccord Genuity

Tip Ranks·
US
PHAR
-0.36%
US
IHE
+1.13%
Tip Ranks·
US
PHAR
-0.36%
US
IHE
+1.13%

Pharming To Present New Leniolisib Pediatric And CVID Data At CIS 2026

nasdaq·
US
PHAR
-0.36%
US
IBBQ
+0.89%
US
VHT
+0.63%
nasdaq·
US
PHAR
-0.36%
US
IBBQ
+0.89%
US
VHT
+0.63%

Pharming Group shares are trading lower after the company reported worse-than-expected Q1 financial results.

benzinga_article·
US
PHAR
-0.36%
US
IBBQ
+0.89%
US
IXJ
+0.71%
benzinga_article·
US
PHAR
-0.36%
US
IBBQ
+0.89%
US
IXJ
+0.71%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
TRDA
+4.22%
US
AGL
-0.50%
US
ATRA
-0.42%
benzinga_article·
US
TRDA
+4.22%
US
AGL
-0.50%
US
ATRA
-0.42%

Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders | PHARM Stock News

StockTitan·
US
PHAR
-0.36%
US
IBB
+0.74%
US
XLV
+0.66%
StockTitan·
US
PHAR
-0.36%
US
IBB
+0.74%
US
XLV
+0.66%

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026 | PHARM Stock News

StockTitan·
US
PHAR
-0.36%
US
PBE
+0.56%
US
BIB
+0.08%
StockTitan·
US
PHAR
-0.36%
US
PBE
+0.56%
US
BIB
+0.08%
© 2026 Longbridge｜Disclaimer